Is Cresco Labs Inc halal to invest in?

According to Musaffa's Shariah screening methodology, Cresco Labs Inc (CL.CN) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Cresco Labs Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cresco Labs Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Cresco Labs Inc?

Muslim investors may consider investing in Cresco Labs Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Cresco Labs Inc classified as NOT HALAL?

Musaffa determines the Shariah status of Cresco Labs Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Cresco Labs Inc updated?

The Shariah compliance status of Cresco Labs Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Cresco Labs Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Cresco Labs Inc?

You can check the latest Shariah compliance status of Cresco Labs Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CL.CN Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 18, 2026

Report Source: 2025 Annual Report

Cresco Labs Inc. Stock Analysis CL.CN

Canada Health Care Small Cap Report: 2025 Annual

Cresco Labs Inc. engages in cultivating medical grade cannabis, manufacturing medical products derived from cannabis cultivation, and distributing such products to medical or adult use consumers. The company is headquartered in Chicago, Illinois and currently employs 2,900 full-time employees. The company went IPO on 2018-12-03. The firm is licensed to cultivate, manufacture, and sell retail and medical cannabis products primarily through Sunnyside, Cresco Labs’ national dispensary brand, and third-party retail stores. Its family brands include Cresco, High Supply, Good News, Wonder Wellness Co., FloraCal Farms, Remedi and Mindy’s. Its portfolio consists of over 500 products. Its products are sold in over 1,400 dispensaries across the country. Cresco offers flower, liquid live resin vapes and concentrates available in a variety of product forms at dispensaries and retail locations. Its High Supply is lab-tested, and available in vape carts, vape pens, flowers, popcorn, shakes, shorties, and concentrates. Its Remedi products provide a consistent and trusted alternative to traditional pharmaceuticals like opioids. Mindy’s offers dosed edibles created by James Beard. The company is the wholesaler of branded cannabis products.

Key Statistics of Cresco Labs Inc (CL.CN)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD1.12CAD1.27

Today's Open

CAD1.26

Volume

351.83K

P/E Ratio (TTM)

52 Week Range

CAD0.60CAD3.12

Market Cap

614.56M

Avg. Volume

311.93K

Dividend Yield

Financial Metrics & Statements of Cresco Labs Inc (CL.CN)

FAQ's for Cresco Labs Inc (CL.CN)

According to Musaffa’s Shariah screening methodology, Cresco Labs Inc (CL.CN) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.